These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26859726)

  • 1. New therapeutic options for skin and soft tissue infections.
    Bassetti M; Righi E; Carnelutti A
    Curr Opin Infect Dis; 2016 Apr; 29(2):99-108. PubMed ID: 26859726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
    Bassetti M; Baguneid M; Bouza E; Dryden M; Nathwani D; Wilcox M
    Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():3-18. PubMed ID: 24580738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early appropriate parenteral antimicrobial treatment of complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus.
    Napolitano LM
    Surg Infect (Larchmt); 2008; 9 Suppl 1():s17-27. PubMed ID: 18844471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
    Itani KM; Biswas P; Reisman A; Bhattacharyya H; Baruch AM
    Clin Ther; 2012 Aug; 34(8):1667-73.e1. PubMed ID: 22770644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral antimicrobial options for the treatment of skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in the UK.
    Enoch DA; Karas JA; Aliyu SH
    Int J Antimicrob Agents; 2009 Jun; 33(6):497-502. PubMed ID: 19101123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
    Itani KM; Weigelt J; Li JZ; Duttagupta S
    Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
    Lawson W; Nathwani D; Eckmann C; Corman S; Stephens J; Solem C; Macahilig C; Li J; Baillon-Plot N; Charbonneau C; Haider S
    Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S40-6. PubMed ID: 26206621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
    Eckmann C; Nathwani D; Lawson W; Corman S; Solem C; Stephens J; Macahilig C; Li J; Charbonneau C; Baillon-Plot N; Haider S
    Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S33-9. PubMed ID: 26198370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections.
    Bassetti M; Carnelutti A; Righi E
    Curr Opin Infect Dis; 2017 Apr; 30(2):150-157. PubMed ID: 28079631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: epidemiology, risk factors, and presentation.
    Dryden M
    Surg Infect (Larchmt); 2008; 9 Suppl 1():s3-10. PubMed ID: 18844473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for skin and soft tissue infections caused by meticillin-resistant Staphylococcus aureus:oralvs.parenteral; home vs. hospital.
    Esposito S; Leone S; Petta E; Noviello S; Ianniello F
    Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S30-5. PubMed ID: 19560673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.
    Eckmann C; Lawson W; Nathwani D; Solem CT; Stephens JM; Macahilig C; Simoneau D; Hajek P; Charbonneau C; Chambers R; Li JZ; Haider S
    Int J Antimicrob Agents; 2014 Jul; 44(1):56-64. PubMed ID: 24928311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daptomycin: rationale and role in the management of skin and soft tissue infections.
    Seaton RA
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii15-23. PubMed ID: 18829721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for MRSA skin and soft-tissue infections.
    Med Lett Drugs Ther; 2014 May; 56(1442):39-40. PubMed ID: 24818839
    [No Abstract]   [Full Text] [Related]  

  • 15. Emerging drugs for complicated skin and skin-structure infections.
    Mendoza N; Tyring SK
    Expert Opin Emerg Drugs; 2010 Sep; 15(3):509-20. PubMed ID: 20557269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in prescriptive practices in skin and soft tissue infections associated with the increased occurrence of community acquired methicillin resistant Staphylococcus aureus.
    Meddles-Torres C; Hu S; Jurgens C
    J Infect Public Health; 2013 Dec; 6(6):423-30. PubMed ID: 23999333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim-sulfamethoxazole0010.
    De Angelis G; Cipriani M; Cauda R; Tacconelli E
    Clin Infect Dis; 2011 Jun; 52(12):1471-2; author reply 1472. PubMed ID: 21628490
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection and initial management of complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus.
    Sawyer RG
    Surg Infect (Larchmt); 2008; 9 Suppl 1():s11-5. PubMed ID: 18844470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus: role of tigecycline.
    Curcio D
    Clin Infect Dis; 2011 Jun; 52(12):1468-9. PubMed ID: 21498390
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections.
    Bounthavong M; Hsu DI
    Expert Rev Pharmacoecon Outcomes Res; 2012 Dec; 12(6):683-98. PubMed ID: 23252352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.